You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 諾輝健康大漲逾14%創4個月新高 3日連漲達35%
格隆匯 01-05 15:04
格隆匯1月5日丨諾輝健康(6606.HK)大幅拉昇漲超14%,3日連漲達35%,現報23.65港元創4個月新高價,總市值重回百億港元。公司與相達生物科技日前宣佈深度戰略合作,全面整合雙方在產品與渠道拓展的優質資源,共同推廣幽幽管在香港市場的銷售。2022年1月18日上市以來,幽幽管截至2022年6月30日實現銷售收入8,350萬元人民幣,並蟬聯京東、天貓平台618及雙11基因檢測單品銷售額冠軍,上榜天貓健康“雙11必買清單”。值得一提的是,精密科學前高管領銜,諾輝健康國際研發中心上月初落户香港。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account